Quantcast

Latest Menorrhagia Stories

2008-08-05 09:01:31

NEWPORT, Ky., Aug. 5 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. announced today positive top line results in two pivotal Phase 3 clinical trials of its proprietary investigational product, a modified-release (MR) formulation of tranexamic acid for the treatment of women with menorrhagia, or heavy menstrual bleeding, and its accompanying symptoms. "We are extremely pleased with the initial data from these pivotal trials and we look forward to continuing to work with the U.S. Food and...

2008-07-21 06:00:17

Repros Therapeutics Inc. (NasdaqGM:RPRX) today announced that the results of the initial Phase I/II clinical trial of Proellex(R) which was conducted in Europe are to be published in US Obstetrics and Gynecology Review in early August. In this study, women with fibroids were treated with Lucrin(R) (also known as Lupron(R)), one of three doses of Proellex, or placebo. Decreases in fibroid size were detected by ultrasound and there was a notable reduction in vaginal bleeding. The drug appeared...

2008-07-17 09:00:19

ANN ARBOR, Mich., July 17 /PRNewswire/ -- Meditrina Pharmaceuticals, Inc. today announced the approval of its second investigational new drug (IND) application for a Phase IIb dose ranging clinical trial to study MPI-676, the Company's aromatase inhibitor (AI), in combination with estrogen and progestin for the treatment of endometriosis. MPI-676 is the newest addition to Meditrina's clinical stage product portfolio that currently includes Femathina(TM) (MPI-674), an AI that Meditrina is...

2008-07-16 18:00:12

Repros Therapeutics Inc. (NasdaqGM:RPRX) today released strong results from its completed extension safety study of Proellex in the chronic treatment of the symptoms associated with uterine fibroids. To date there have been no abnormal histological findings from the endometrial biopsies taken post menses after cessation of drug administration. As of this release, results from 13 women who had endometrial biopsies post menses following last dose of drug in a two-drug cycle extension study...

2008-07-10 09:01:29

WALTHAM, Mass., July 10 /PRNewswire/ -- According to Millennium Research Group's Global Markets for Hysterectomy Alternatives 2008 report, which covers global endometrial ablation (GEA) devices, uterine artery embolization (UAE) devices, hysteroscopes, and endometrial resection devices, the global hysterectomy market will generate more than $700 million in 2012, primarily driven by expanding GEA procedure volumes. In the US and UK, the availability of a sufficient level of reimbursement...

2008-07-01 21:00:05

By Anna Tong, The Lexington Herald-Leader, Ky. Jul. 1--A medical malpractice case in which an Owingsville woman accused a Lexington gynecologist of unnecessary castration -- removing her healthy ovaries -- without warning her of the surgery's consequences went to the jury Tuesday. The defense argued that the doctor used sound medical judgment. "He's done the worst thing a physician can do -- he violated her trust," said Lexington attorney, Sheila Hiestand. The plaintiff, 38 year-old...

ea090aef59365c1ace53d350a060ec061
2008-06-30 15:31:19

A new study from researchers at the University of Iowa has found that shortened times between menstrual periods may be an initial sign of menopause, while heavy bleeding seems to have other causes.  The researchers found that a shortened interval between periods, fewer than 21 days, in women aged 42 to 52 indicated the women were in the early stages of menopause. These periods were often "anovulatory", meaning the women did not ovulate even though they experienced bleeding. The...

2008-06-24 18:01:16

By Anna Tong, The Lexington Herald-Leader, Ky. Jun. 24--Attorneys delivered opening statements Tuesday in a malpractice trial involving one of six women who accused a Lexington obstetrician and gynecologist of unnecessarily removing their ovaries. The lawsuit, originally filed in 2003, claims that Dr. Michael Guiler performed medically unnecessary oophorectomies, needlessly leaving the women at risk for breast cancer, embolisms and dementia because they can no longer produce their own...

2008-06-24 02:29:21

Most women experience some discomfort during their periods. But for some, the pain is so excruciating and severe that it could be a sign of an underlying condition. Three years ago, Exeter pharmacist Philippa Houchin, who had suffered heavy, painful periods since she was a teenager, was diagnosed with adenomyosis, a condition which is similar to endometriosis. She said: "On a monthly basis, I was experiencing huge amounts of pain. I was able to work, but on some days, it was a struggle...

2008-06-20 18:00:39

Pycnogenol, bark extract from a French maritime pine tree, helped alleviate extremely painful menstrual periods, Japanese researchers said. The study showed women with dysmenorrhea -- extremely painful menstrual periods -- who took Pycnogenol experienced less pain and required less pain medications during menstruation. Non-steroid anti-inflammatory drugs, or NSAIDs, like aspirin or ibuprofen provide temporary help against menstrual pain, lead researcher Dr. Nobutaka Suzuki said in a...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.